sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÓÕ·¢ÐÔÌØÓ¦ÐÔÆ¤Ñ×¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > ÓÕ·¢ÐÔÌØÓ¦ÐÔÆ¤Ñ×¶¯ÎïÄ£×Ó

ǰÑÔ

ÌØÓ¦ÐÔÆ¤Ñ×(atopic dermatitis, AD)ÊÇÒ»ÖÖÂýÐÔ¡¢Öظ´±¬·¢ÐÔÑ×Ö¢ÐÔÆ¤·ô²¡ £¬Ö÷ÒªÌåÏÖΪǿÁÒµÄðþÑ÷¡¢ÏÔ×ŵÄʪÕîÑù±äºÍƤ·ô¸ÉÔï¡£Î÷·½Å¹ú¼Ò¶ùͯADµÄ·¢²¡Âʸߴï10£¥¡«20£¥ £¬ÔÚ³ÉÈËÖз¢²¡ÂÊԼΪ1£¥~3£¥¡£2000Äê £¬ÊÓ²ìЧ¹ûÏÔʾÎÒ¹úÇàÉÙÄêÌØÓ¦ÐÔÆ¤Ñ׵ķ¢²¡ÂÊΪ0.69£¥¡£ADµÄ²¡ÒòÖØ´ó £¬ÏÖÔÚÒÔΪÆä¿ÉÄÜÓëÒÅ´«¡¢ÇéÐÎÒòËØ¡¢Ñ¬È¾¡¢Æ¤·ôÆÁÕϹ¦Ð§Òì³£¡¢Th1/Th2ʧºâ¼°Éñ¾­ÃâÒßÒì³£µÈ¶àÖÖÒòËØÓйØ¡£³£°éÓÐСÎÒ˽¼Ò¼°¼Ò×åÌØÓ¦ÐÔ²¡Ê·£¨Ïø´­¡¢¹ýÃôÐÔ±ÇÑ׵ȣ©¡£ÏÖÔÚÔÚÖÎÁÆÉÏ £¬¹ØÓÚADÉÐÎÞÖª×ã¼Æ»®¡£ÎÞÂÛ¹ØÓÚ̽Ë÷·¢²¡»úÖÆÕÕ¾ÉѰÕÒÓÐÓõÄÖÎÁÆÒ©Îï £¬AD¶¯ÎïÄ£×Ó¶¼ÏÔµÃÓÈΪÖ÷Òª¡£ÏÖÔÚ £¬AD¶¯ÎïÄ£×ÓÖ÷Òª·ÖΪ×Ô¾õÐÔÄ£×Ó¡¢¿¹Ô­ÓÕµ¼¶¯ÎïÄ£×ÓÒÔ¼°»ùÒòÐÞÊζ¯ÎïÄ£×Ó¡£

 

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

С·Ö×ӵİ뿹ԭÓëÌåÄÚÂѰ×ÖÊÍŽá³ÉÍêÈ«¿¹Ô­ £¬¾­ÀʸñººË¹Ï¸°ûÉãÈ¡²¢Ìá³Ê¸øTϸ°û £¬Ê¹Æä»î»¯¡¢·Ö½âΪЧӦTϸ°û £¬»úÌåÔٴνӴ¥ÏìÓ¦¿¹Ô­¿É±¬·¢½Ó´¥ÐÔÆ¤Ñס£

³¬¿¹Ô­ÓÉ¢òÐÍÖ÷Òª×éÖ¯ÏàÈݸ´ºÏÎï(MHC ¢ò)·Ö×Ó³ÊµÝ £¬È´²»×÷ÓÃÓÚMHCµÄ¿¹Ô­ÍŽá²Û¡£ÍêÕûµÄ³¬¿¹Ô­Ó뿹ԭÍŽá²ÛÍâµÄÊØ¾É°±»ùËá²Ð»ùÍŽá¡£Ö±½ÓÓëרְ¿¹Ô­³ÊµÝϸ°û»òϸ°ûÒò×ÓÓÕµ¼µÄ·Çרְ¿¹Ô­³ÊµÝϸ°ûÍŽá £¬¼¤»îÑ×Ö¢·´Ó¦¡£³¬¿¹Ô­»¹¿ÉÒÔ¼¤»îBÁܰÍϸ°û»ò´Ì¼¤Tϸ°û»î»¯²¢À©´óÁܰÍϸ°û±í´ïÌØÒìÐÔµÄTϸ°ûÊÜÌåVβÇøÓ°ÏìÑ×Ö¢»ò×ÔÉíÃâÒß¡£

¡¾Ä£×ÓÌØµã¡¿£º

³£Óõİ뿹ԭÊǶþÏõ»ùÂȱ½(dinitrochlorobenzene)¡£½«¶þÏõ»ùÂȱ½Öظ´ÍâÍ¿7ÖܵÄNc/NgaСÊóµÄ×ãµæºÍ¸¹²¿ÒÔ¼°Ë«¶úºÍ±³²¿ £¬7ÖܺóÊÜÊÔ²¿Î»Æ¤·ô·ºÆðºì°ß¡¢ÉøÍ¸¡¢±íƤ°þÍѵÈADÑùÍâ¹Û £»×éÖ¯²¡ÀíÇÐÆ¬ÏÔʾСÊó±íƤÔöºñ¡¢½Ç»¯Ì«¹ý¡¢Ï¸°û¼äË®Ö× £¬±íƤºÍÕæÆ¤ÄÚ´óÁ¿Ñ×ÐÔϸ°û½þÈó¡£ÑªÒºÖÐ1L-4ºÍIgEµÄˮƽÉý¸ß¡£

ÂÑÇåÂѰ×(ovalbumin)ÊÇ¿ÉÒÔ¼ÓÖØADµÄÒ»ÖÖ±äÓ¦Ô­¡£¶à´Î¾­Æ¤¸øÒ©ºó £¬¾Ö²¿·ºÆð¼¬²ã·Êºñ¡¢±íƤÖжȺ£ÃàË®Ö× £¬ÕæÆ¤Ñª¹ÜÀ©ÕųäѪ°é½ºÔ­ÏËάÔöÉú £¬¿É¼ûÊÈËáÐÔÁ£Ï¸°û¡¢ÖÐÐÔÁ£Ï¸°û¡¢½¬Ï¸°û¡¢ÁܰÍϸ°û½þÈó £»ÑªÇåÖÐ×ÜIgEˮƽÏÔÖøÉý¸ß¡£Æ¤Ëð¾Ö²¿IL-4ºÍIL-5 mRNA±í´ïÏÔÖøÔöÌí £¬IFN mRNAÎÞÏÔ×Åת±ä £¬ËµÃ÷ƤËð¾Ö²¿±£´æTh2½éµ¼µÄϸ°ûÃâÒß¡£

½«³¬¿¹Ô­ÆÏÌÑÇò¾ú³¦¶¾ËØBͿĨÔÚBALB/cСÊóµÄ±³²¿ £¬¿ÉÓÕµ¼Æä±¬·¢Æ¤Ñ׸ıä¡£ÊÜÊÔ²¿Î»·ºÆðÊÈËáÐÔÁ£Ï¸°û½þÈó¼°·Ê´óϸ°ûÔöÉú £¬²¢ÇÒÆäÊýÁ¿Ó볬¿¹Ô­¶¨Ö²»òѬȾ³ÊÕýÏà¹Ø £¬IL-13 mRNAµÄ±í´ïÏÔÖøÔöÌí¡£

ÆäËûµÄ¶¯ÎïÄ£×Ó»¹°üÀ¨ÍâÓ÷۳¾òýÌáÈ¡ÎïµÈ £¬ÓÈÆäÁîÈ˸ÐÐËȤµÄÊÇ £¬½«Å£ÄÌ»ò»¨ÉúÓë×ô¼Á»ôÂÒ¾ú¶¾ËØ»ìÏýÔÚÒ»Æð¹àθ £¬Í¬Ñù¿ÉÒÔÒýÆð´ÆÐÔC3H/HeJСÊ󱬷¢AD±íÐÍ¡£´ËÄ£×ÓÊǵÚÒ»¸öͨ¹ý¹àθ·½·¨»ñµÃµÄAD¶¯ÎïÄ£×Ó £¬Îª½øÒ»²½Ñо¿Ê³ÎïÓÕ·¢µÄADÌṩÁ˺ÏÊʵÄСÊóÄ£×Ó¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

¿¹Ô­ÓÕµ¼µÄAD¶¯ÎïÄ£×Ó×îÍ»³öµÄÓÅÊÆÔÚÓÚ¿É´óÁ¿Öظ´½¨Éè £»Æä´Î £¬´ËÀàÄ£×ÓÔÚ²î±ðµÄ½Ç¶È·´Ó¦ÁËAD·¢²¡»úÖÆµÄ¶àÑùÐÔÓëÖØ´óÐÔ £¬Îª³äÇå³þÈ·AD·¢²¡»úÖÆ¡¢Ì½Ë÷ÖÎÁÆÒ©ÎïÌṩÁËÓÅÒìµÄƽ̨¡£

 

²Î¿¼ÎÄÏ×£º

1.ÔÆÇç £¬Ñî¸ßÔÆ £¬ÎÚÈÕÄÈ£®Ð¡ÊóÄ£×ÓÔÚÌØÓ¦ÐÔÆ¤Ñ×·½ÃæµÄÑо¿Ï£Íû£®ÁÙ´²ºÍʵÑéҽѧÔÓÖ¾ £¬2012, 11 (22):1827-1829

2.¶­Õý°î £¬ÕÅÃÀ»ª£®ÌØÓ¦ÐÔÆ¤Ñ×СÊóÄ£×ÓÑо¿Ï£Íû£®¹ú¼ÊƤ·ôÐÔ²¡Ñ§ÔÓÖ¾ £¬2006, 32 (1):32-34

3.Scharschmidl TC,Segre JA. Modeling atopic dermatitis with increasingly complex mouse models. J Invest DermatoI, 2008, 128 (5): 1061- 1064

4.Tanaka A,Amagai Y,Oida K,et al. Recent findings in mouse models for human atopic dermatitis. Exp Anim, 2012,61 (2):77-84

5.Turner MJ, Travers JB, Kaplan MH. T helper cell subsets in the development of atopic dennalitis. J Drugs Dermatol, 2012, 11 (10): 1174-1178

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > ÓÕ·¢ÐÔÌØÓ¦ÐÔÆ¤Ñ×¶¯ÎïÄ£×Ó
ÓÕ·¢ÐÔÌØÓ¦ÐÔÆ¤Ñ×¶¯ÎïÄ£×Ó

ǰÑÔ

ÌØÓ¦ÐÔÆ¤Ñ×(atopic dermatitis, AD)ÊÇÒ»ÖÖÂýÐÔ¡¢Öظ´±¬·¢ÐÔÑ×Ö¢ÐÔÆ¤·ô²¡ £¬Ö÷ÒªÌåÏÖΪǿÁÒµÄðþÑ÷¡¢ÏÔ×ŵÄʪÕîÑù±äºÍƤ·ô¸ÉÔï¡£Î÷·½Å¹ú¼Ò¶ùͯADµÄ·¢²¡Âʸߴï10£¥¡«20£¥ £¬ÔÚ³ÉÈËÖз¢²¡ÂÊԼΪ1£¥~3£¥¡£2000Äê £¬ÊÓ²ìЧ¹ûÏÔʾÎÒ¹úÇàÉÙÄêÌØÓ¦ÐÔÆ¤Ñ׵ķ¢²¡ÂÊΪ0.69£¥¡£ADµÄ²¡ÒòÖØ´ó £¬ÏÖÔÚÒÔΪÆä¿ÉÄÜÓëÒÅ´«¡¢ÇéÐÎÒòËØ¡¢Ñ¬È¾¡¢Æ¤·ôÆÁÕϹ¦Ð§Òì³£¡¢Th1/Th2ʧºâ¼°Éñ¾­ÃâÒßÒì³£µÈ¶àÖÖÒòËØÓйØ¡£³£°éÓÐСÎÒ˽¼Ò¼°¼Ò×åÌØÓ¦ÐÔ²¡Ê·£¨Ïø´­¡¢¹ýÃôÐÔ±ÇÑ׵ȣ©¡£ÏÖÔÚÔÚÖÎÁÆÉÏ £¬¹ØÓÚADÉÐÎÞÖª×ã¼Æ»®¡£ÎÞÂÛ¹ØÓÚ̽Ë÷·¢²¡»úÖÆÕÕ¾ÉѰÕÒÓÐÓõÄÖÎÁÆÒ©Îï £¬AD¶¯ÎïÄ£×Ó¶¼ÏÔµÃÓÈΪÖ÷Òª¡£ÏÖÔÚ £¬AD¶¯ÎïÄ£×ÓÖ÷Òª·ÖΪ×Ô¾õÐÔÄ£×Ó¡¢¿¹Ô­ÓÕµ¼¶¯ÎïÄ£×ÓÒÔ¼°»ùÒòÐÞÊζ¯ÎïÄ£×Ó¡£

 

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

С·Ö×ӵİ뿹ԭÓëÌåÄÚÂѰ×ÖÊÍŽá³ÉÍêÈ«¿¹Ô­ £¬¾­ÀʸñººË¹Ï¸°ûÉãÈ¡²¢Ìá³Ê¸øTϸ°û £¬Ê¹Æä»î»¯¡¢·Ö½âΪЧӦTϸ°û £¬»úÌåÔٴνӴ¥ÏìÓ¦¿¹Ô­¿É±¬·¢½Ó´¥ÐÔÆ¤Ñס£

³¬¿¹Ô­ÓÉ¢òÐÍÖ÷Òª×éÖ¯ÏàÈݸ´ºÏÎï(MHC ¢ò)·Ö×Ó³ÊµÝ £¬È´²»×÷ÓÃÓÚMHCµÄ¿¹Ô­ÍŽá²Û¡£ÍêÕûµÄ³¬¿¹Ô­Ó뿹ԭÍŽá²ÛÍâµÄÊØ¾É°±»ùËá²Ð»ùÍŽá¡£Ö±½ÓÓëרְ¿¹Ô­³ÊµÝϸ°û»òϸ°ûÒò×ÓÓÕµ¼µÄ·Çרְ¿¹Ô­³ÊµÝϸ°ûÍŽá £¬¼¤»îÑ×Ö¢·´Ó¦¡£³¬¿¹Ô­»¹¿ÉÒÔ¼¤»îBÁܰÍϸ°û»ò´Ì¼¤Tϸ°û»î»¯²¢À©´óÁܰÍϸ°û±í´ïÌØÒìÐÔµÄTϸ°ûÊÜÌåVβÇøÓ°ÏìÑ×Ö¢»ò×ÔÉíÃâÒß¡£

¡¾Ä£×ÓÌØµã¡¿£º

³£Óõİ뿹ԭÊǶþÏõ»ùÂȱ½(dinitrochlorobenzene)¡£½«¶þÏõ»ùÂȱ½Öظ´ÍâÍ¿7ÖܵÄNc/NgaСÊóµÄ×ãµæºÍ¸¹²¿ÒÔ¼°Ë«¶úºÍ±³²¿ £¬7ÖܺóÊÜÊÔ²¿Î»Æ¤·ô·ºÆðºì°ß¡¢ÉøÍ¸¡¢±íƤ°þÍѵÈADÑùÍâ¹Û £»×éÖ¯²¡ÀíÇÐÆ¬ÏÔʾСÊó±íƤÔöºñ¡¢½Ç»¯Ì«¹ý¡¢Ï¸°û¼äË®Ö× £¬±íƤºÍÕæÆ¤ÄÚ´óÁ¿Ñ×ÐÔϸ°û½þÈó¡£ÑªÒºÖÐ1L-4ºÍIgEµÄˮƽÉý¸ß¡£

ÂÑÇåÂѰ×(ovalbumin)ÊÇ¿ÉÒÔ¼ÓÖØADµÄÒ»ÖÖ±äÓ¦Ô­¡£¶à´Î¾­Æ¤¸øÒ©ºó £¬¾Ö²¿·ºÆð¼¬²ã·Êºñ¡¢±íƤÖжȺ£ÃàË®Ö× £¬ÕæÆ¤Ñª¹ÜÀ©ÕųäѪ°é½ºÔ­ÏËάÔöÉú £¬¿É¼ûÊÈËáÐÔÁ£Ï¸°û¡¢ÖÐÐÔÁ£Ï¸°û¡¢½¬Ï¸°û¡¢ÁܰÍϸ°û½þÈó £»ÑªÇåÖÐ×ÜIgEˮƽÏÔÖøÉý¸ß¡£Æ¤Ëð¾Ö²¿IL-4ºÍIL-5 mRNA±í´ïÏÔÖøÔöÌí £¬IFN mRNAÎÞÏÔ×Åת±ä £¬ËµÃ÷ƤËð¾Ö²¿±£´æTh2½éµ¼µÄϸ°ûÃâÒß¡£

½«³¬¿¹Ô­ÆÏÌÑÇò¾ú³¦¶¾ËØBͿĨÔÚBALB/cСÊóµÄ±³²¿ £¬¿ÉÓÕµ¼Æä±¬·¢Æ¤Ñ׸ıä¡£ÊÜÊÔ²¿Î»·ºÆðÊÈËáÐÔÁ£Ï¸°û½þÈó¼°·Ê´óϸ°ûÔöÉú £¬²¢ÇÒÆäÊýÁ¿Ó볬¿¹Ô­¶¨Ö²»òѬȾ³ÊÕýÏà¹Ø £¬IL-13 mRNAµÄ±í´ïÏÔÖøÔöÌí¡£

ÆäËûµÄ¶¯ÎïÄ£×Ó»¹°üÀ¨ÍâÓ÷۳¾òýÌáÈ¡ÎïµÈ £¬ÓÈÆäÁîÈ˸ÐÐËȤµÄÊÇ £¬½«Å£ÄÌ»ò»¨ÉúÓë×ô¼Á»ôÂÒ¾ú¶¾ËØ»ìÏýÔÚÒ»Æð¹àθ £¬Í¬Ñù¿ÉÒÔÒýÆð´ÆÐÔC3H/HeJСÊ󱬷¢AD±íÐÍ¡£´ËÄ£×ÓÊǵÚÒ»¸öͨ¹ý¹àθ·½·¨»ñµÃµÄAD¶¯ÎïÄ£×Ó £¬Îª½øÒ»²½Ñо¿Ê³ÎïÓÕ·¢µÄADÌṩÁ˺ÏÊʵÄСÊóÄ£×Ó¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

¿¹Ô­ÓÕµ¼µÄAD¶¯ÎïÄ£×Ó×îÍ»³öµÄÓÅÊÆÔÚÓÚ¿É´óÁ¿Öظ´½¨Éè £»Æä´Î £¬´ËÀàÄ£×ÓÔÚ²î±ðµÄ½Ç¶È·´Ó¦ÁËAD·¢²¡»úÖÆµÄ¶àÑùÐÔÓëÖØ´óÐÔ £¬Îª³äÇå³þÈ·AD·¢²¡»úÖÆ¡¢Ì½Ë÷ÖÎÁÆÒ©ÎïÌṩÁËÓÅÒìµÄƽ̨¡£

 

²Î¿¼ÎÄÏ×£º

1.ÔÆÇç £¬Ñî¸ßÔÆ £¬ÎÚÈÕÄÈ£®Ð¡ÊóÄ£×ÓÔÚÌØÓ¦ÐÔÆ¤Ñ×·½ÃæµÄÑо¿Ï£Íû£®ÁÙ´²ºÍʵÑéҽѧÔÓÖ¾ £¬2012, 11 (22):1827-1829

2.¶­Õý°î £¬ÕÅÃÀ»ª£®ÌØÓ¦ÐÔÆ¤Ñ×СÊóÄ£×ÓÑо¿Ï£Íû£®¹ú¼ÊƤ·ôÐÔ²¡Ñ§ÔÓÖ¾ £¬2006, 32 (1):32-34

3.Scharschmidl TC,Segre JA. Modeling atopic dermatitis with increasingly complex mouse models. J Invest DermatoI, 2008, 128 (5): 1061- 1064

4.Tanaka A,Amagai Y,Oida K,et al. Recent findings in mouse models for human atopic dermatitis. Exp Anim, 2012,61 (2):77-84

5.Turner MJ, Travers JB, Kaplan MH. T helper cell subsets in the development of atopic dennalitis. J Drugs Dermatol, 2012, 11 (10): 1174-1178

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿